Utilization of electronic journals as a learning resource for students Poltekkes Kemenkes of North Sumatera

Abdi Mubarak Syam

Abstract


Typhoid fever is a global health problem, especially in developing countries, one of which is Indonesia. The incidence of resistance to the use of antibiotics in the treatment of typhoid fever can occur due to inappropriate use of antibiotics. This study aims to determine the impact of the application of clinical pathways on the quality and quantity of antibiotic use in typhoid therapy at FMC Bogor Hospital. This research is a descriptive analytic study conducted retrospectively which was analyzed using the Gyssens and ATC/DDD methods. The research data was taken from patient medical records for the period January-December 2018 and January-December 2020 which met the inclusion criteria. The results showed that from 115 medical records of typhoid fever patients, ceftriaxone was used as the most widely used antibiotic for typhoid therapy. The quality of antibiotic use as much as 40% was declared rational before the use of clinical pathways and as much as 57.3% after the use of clinical pathways (category 0), while the other 60% were irrational (categories I-VI) and after CP as much as 42.7% were included in category 0, the rest fall into the irrational category (Categories I-VI) which includes the use of antibiotics that are not appropriate for the administration interval, the use of antibiotics that are too long, the use of antibiotics that are too short, there are other antibiotics that are more effective, and there are other antibiotics that are less toxic /safer. The quantity of antibiotic use was stated to exceed WHO standards, namely the use of ceftriaxone by 81 DDD/100 patient days before the clinical pathway and 92.4 DDD/100 patient days after the clinical pathway. Based on the results of statistical tests, it was obtained 1) There were differences in the quality of antibiotic use between before and after the implementation of the clinical pathway in inpatients with typhoid fever at FMC Bogor Hospital; 2) There are differences in the quantity of antibiotic use between before and after the implementation of the clinical pathway in inpatients with typhoid fever at FMC Bogor Hospital. The results of this study are expected to be a consideration for the hospital as material for evaluation and improvement in order to increase the rationality of using antibiotics.

Full Text:

PDF

References


United States Centers for Disease Control and Prevention.Antibiotic Resistance Threats in the United States 2019. United States Department of Health and Human Services; 2019,h. 101-102

Ministry of Health of the Republic of Indonesia. Systematic Guidelines for Typhoid Fever Control 2013. Jakarta: Directorate General of Disease Control and Environmental Health. Jakarta 2013. h 42-20

Ainil Maksura. Typhoid Fever Incidence Rate Based on Serological Examination at Hasanuddin University Hospital Makassar, Tamalanrea Jaya Health Center and Tamalanrea Health Center in 2019-2020 (Thesis). Makassar: Faculty of Medicine, University of Hasanuddin Makassar; 2021, pp 2-33

Jeffrey, Robert, et.all. The Global Burden of Typhoid and Paratyphoid Fever: a systematic analysis for the Global Burden of Disease Study 2017. Global Burden United State; 2017. pp 380-369

Pieter Hazmen, Shirly Kumala, Prih Sarnianto. Cost Analysis of Typhoid Fever Treatment Based onClinical Pathwaysat Hope Mother Hospital. Journal of the Medical Profession. 2019; 13(2): 81-74.

Ministry of Health of the Republic of Indonesia. Decree of the Minister of Health No. 34 of 2006 concerning Typhoid Fever. Jakarta: Ministry of Health of the Republic of Indonesia; 2006. h 28-3.

Grace D. Appiah, Michael J. Hughes, Kevin Chatham-Stephens. The CDC Yellow Book 2020. United States: Chapter 4 Travel-Related Infectious Disease Typhoid and Paratyphoid Fever: p 5-1. [accessed June 15, 2022]. Accessed from:https://wwwnc.cdc.gov/travel/yellowbook/2020/travel-related-infectious-diseases/typhoid-and-paratyphoid-fever

Sukmawati, Jaya, et al. Evaluation of the use of antibiotics in inpatient typhoid patients at a Bali provincial government hospital using the Gyssens and ATC/DDD methods. Udayana Pharmacy Journal, Bali; 2020. pp 43-37

Ministry of Health of the Republic of Indonesia. Regulation of the Minister of Health of the Republic of Indonesia Number 8 of 2015 concerning the Antimicrobial Resistance Control Program. Jakarta: Ministry of Health of the Republic of Indonesia; 2015. pp 26-320

Ministry of Health of the Republic of Indonesia. Regulation of the Minister of Health of the Republic of Indonesia Number 1438 of 2010 concerning Medical Service Standards. Jakarta: Ministry of Health of the Republic of Indonesia; 2010, pp 5-2.

Hospital Accreditation Committee. National Standards for Hospital Accreditation Edition 1 of 2018. Jakarta: Hospital Accreditation Committee; 2017. h. 389-65

Ministry of Health of the Republic of Indonesia. Regulation of the Minister of Health Number 2406 Concerning General Guidelines for the Use of Antibiotics. Jakarta: Ministry of Health of the Republic of Indonesia; 2011. pp 60–5

Nagshetty et al. Antimicrobial suspectibility of Salmonella Typhi in India. The Journal of Infection In Developing Countries. India: 2010; 4 (2) h. 73-70.

Sutisna, NS The Importance of Clinical Pathway for Health Facilities [Internet]. {accessed December 22, 2020}. Accessed from:https://www.alomedika.com/pentingnya-clinical-pathway-for health facilities

Paul UK, Bandyopadhyay A. Typhoid fever: a review. International Journal of Advances in Medicine. March-April 2017;4(2):300-306

Sumarno, Herry, et. All. Textbook of Infection and Tropical Pediatrics Second Edition, 2008. Jakarta: Indonesian Pediatrician Association; 2008. pp 346-338

Zulfiqar A. Bhutta. Typhoid Fever Currents Concepts. Department of Pediatrics and Child Health, Pakistan; 2006. pp 271-266

Lusy Noviani. Practical Guide for Pharmacists in Implementing Antibiotic Resistance Control Programs in Hospitals. Jakarta: ISFI Publishing; 2019. pp 90-9.

Sunarjati, Mechanisms of Antibiotic Resistance in Bacterial Infections. Department of Microbiology, Faculty of Medicine, Padjadjaran University, Indonesia; 2015.

Gould IM, Meer JWM van der. Antibiotic policies: Theory and practice. Kluwer Academic Publisher New. New York; 2005, pp 1–766.

WHO, 2022. Guidelines for ATC Classification and DDD Assignment 20021. Oslo: WHO Collaborating Center for Drug Statistics Methodology Oslo, Norwegian Institute of Public Health: Oslo; 2022. pp 149-10

Ministry of Health of the Republic of Indonesia. Guidelines for Pharmaceutical Services for Antibiotic Therapy 2011. Jakarta: Ministry of Health of the Republic of Indonesia; 2011. pp 40-27

Imas Masturoh, Nauri Anggita, Health Research Methodology, 1st edition: Development and Empowerment Agency for Health Human Resources: Jakarta; 2018. pp 193-104

FMC Hospital. FMC Hospital Typhoid Fever Clinical Pathway 2020: Bogor; 2020. h 24-19

Etikasari, R., Andayani, TM and Mukti, AG2012. Cost Analysis and Appropriateness of Using Antibiotics in Typhoid Fever in Yogyakarta City Hospital. Journal of Pharmaceutical Management and Services. 2(2); 2012. pp 147-153.

Enjelina S, Adam MR, Erwin S. Evaluation of the Quantitative and Qualitative Use of Antibiotics in Digestive Surgery Patients at Abdul Wahab Sjahranie Hospital, Samarinda. Results of Pharmaceutical Research and Development "Tropical Pharmacy" 2021. Samarinda: Faculty of Pharmacy, Mulawarman University; 2021, pp 220-214

Vani R., Keri L., Review: Management of Typhoid Fever Therapy: 2018 Pharmacological and Non-Pharmacological Therapeutic Studies. West Java: Pharmacological Supplements 16 (1); 2018. pp 184-195

Gyssens, IC, 2005, Audit for Monitoring the Quality of Antimicrobial Prescription, In: Gould, IM, Van der Meer, Editors, Antibiotic Policies: Theory and Practice Kluwer Academic Publishers, New York: p 192-208

Rampengan, NH 2013. Antibiotic Therapy for Typhoid Fever without Complications in Children 2013. Manado: Sari Pediatrics, Faculty of Medicine, University of Sam Ratulangi 2013; 14(5). pp 276-271

Association of Indonesian Internal Medicine Specialists, 2006, Medical Service Standards, PB PABDI, Jakarta.

Cammie F. Lesser, Samuel I. Miller, 2005. Salmonellosis. Harrison's Principles of Internal Medicine (16th ed), 897-900.

Adiwisastra, Nuzul Gyanata, et al. 2019.Effectiveness of Clinical Pathway Implementation in Acute Gastroenteritis (GEA) Pediatric Patients with Dehydration Hospitalized at Permata Bekasi Hospital. Journal of Medical Professions.Vol 1, No 3 (2019)

Firmansyah, Yohanes and Widjaja Gunawan. 2022. Application of Clinical Pathway in Health Care and Its Legal Consequences. Hutama Medical Journal. Vol. 3 No. 2




DOI: http://dx.doi.org/10.30829/contagion.v3i2.15339

Refbacks

  • There are currently no refbacks.


Copyright (c) 2023 Abdi Mubarak Syam

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

 
Contagion: Scientific Periodical Journal of Public Health and Coastal Health by Program Studi Ilmu Kesehatan Masyarakat is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.